ArticleCureus2024
Evaluating the Efficacy of Common Femoral Endarterectomy With Profundoplasty: A Three-Year Single-Center Perspective.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anatomical Predictors of Clinical Improvement After Profundoplasty in Patients with an Occluded Superficial Artery: A Pilot Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to synthesise recent findings on the outcomes of common femoral endarterectomy (CFE) with profundoplasty, evaluating the efficacy, complications, and predictors of long-term success in patients undergoing this procedure. PATIENTS AND
methodsThis is a descriptive retrospective study assessing the outcomes of CFE with profundoplasty. All patients with chronic limb-threatening ischaemia (CLTI) who attended and underwent CFE with profundoplasty with or without iliac intervention at Glan Clwyd Hospital (Wales, United Kingdom) were studied. We excluded the patients who had the CFE as part of bypass surgery.
resultsIn a period of three years, 77 patients were included. Forty-six (59.7%) of them were male, and 31 (40.3%) of them were female. The mean age was 73.3 ± 7.8 years (standard deviation). Regarding the comorbidity, hypertension and smoking were recorded for most of the patients, while the other comorbidities were less frequent. The majority of the patients are presented with rest pain 70.1% (n = 54), while the remainder has both rest pain and tissue loss. Forty patients (51.9%) had CFE as part of the hybrid operation with iliac angioplasty; however, only 37 patients (48.1%) had CFE. The most reported complications postoperatively were groin infection, hospital-acquired pneumonia, and thrombosis, with less reporting for the rest of the complications. The limb salvage rate was 74% (n = 57); moreover, the mean primary patency rate was 10.7 + 8.4 months SD.
conclusionThe CFE is a feasible operation, either isolated or in conjunction with iliac angioplasty, with a satisfactory patency rate. It can be offered to the high-risk group of patients. However, they are going to need a rigorous follow-up to avoid or minimise postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.